This €/month helps us finance the research and therapies that make April in the best physical and cognitive conditions. The total cost of the research is estimated at €450,000 and the manufacturing of the drug is close to €2M. Abril's physical and cognitive therapies represent a significant expense for Abril's family and with this help we can ensure that she is in optimal conditions for a possible cure after investigation.